Retired British professional footballer Ray Clarke, diagnosed with early-onset Alzheimer's, is participating in a clinical trial to slow or stop the progression of the disease. Drawing on a history of head injuries, Ray joins Dr. Emer MacSweeney, CEO and Medical Director of Re:Cognition Health, and Tom Dent, Executive Chairman of Re:Cognition Health, to urge former contact sport athletes to seek early testing and treatment for neurological issues.